首页> 外文期刊>Minimally invasive therapy and allied technologies: MITAT : official journal of the Society for Minimally Invasive Therapy >Digital patient models based on Bayesian networks for clinical treatment decision support
【24h】

Digital patient models based on Bayesian networks for clinical treatment decision support

机译:基于贝叶斯网络的临床治疗决策支持数字患者模型

获取原文
获取原文并翻译 | 示例
           

摘要

Increasing complexity in the management of oncologic diseases due to advances in diagnostics and individualized treatments demands new techniques of comprehensive decision support. Digital patient models (DPMs) are developed to collect, structure, and evaluate information to improve the decision-making process in tumour boards and surgical procedures in the operating room (OR). Laryngeal cancer (LC) was selected as a prototype to build a clinical decision support system (CDSS) based on Bayesian networks (BN). The model was built in cooperation with a knowledge engineer and a domain expert in head and neck oncology. Once a CDSS is developed, individual patient data can be set to compute a patient-specific BN. The modelling was based on clinical guidelines and analysis of the tumour board decision making. Besides description of the modelling process, recommendations for standardised modelling, new tools, validation and interaction of extensive models are presented. The LC model contains over 1,000 variables with about 1,300 dependencies. A subnetwork representing TNM staging (303 variables) was validated and reached 100% of correct model predictions. Given the new methods and tools, construction of a complex human-readable CDSS is feasible. Interactive platforms with guided modelling may support collaborative model development and extension to other diseases. Appropriate tools may assist decision making in various situations, e.g. the OR.
机译:由于诊断和个性化治疗的进展,由于诊断和个性化治疗的进展,肿瘤疾病管理的复杂性需要新的综合决策支持。开发数字患者模型(DPMS)以收集,结构和评估信息,以改善肿瘤板中的决策过程和手术室(或)中的手术程序。选择喉癌(LC)作为基于贝叶斯网络(BN)构建临床决策支持系统(CDSS)的原型。该模型与知识工程师和头部和颈部肿瘤的域专家合作建立。开发CDSS后,可以将个别患者数据设置为计算患者特定的BN。该建模基于临床指南和肿瘤委员会决策的分析。除了对建模过程的描述之外,还提出了用于标准化建模,新工具,验证和广泛模型交互的建议。 LC模型包含超过1,000个变量,约1,300个依赖项。验证代表TNM分期(303变量)的子网,并达到了100%的正确模型预测。鉴于新的方法和工具,复杂的人类可读CDS的构建是可行的。带导游建模的互动平台可能支持协作模型开发和扩展到其他疾病。适当的工具可以帮助各种情况下的决策,例如,或。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号